The Latin America, Middle East and Africa Demineralized Bone Matrix Market would witness market growth of 8.1% CAGR during the forecast period (2023-2030).
The Brazil market dominated the LAMEA Demineralized Bone Matrix Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $39 million by 2030. The Argentina market is showcasing a CAGR of 8.7% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7.8% during (2023 - 2030).
DBM-based grafting materials facilitate the successful placement of dental implants and improve long-term implant outcomes in patients requiring tooth replacement. In addition, DBM is utilized in periodontal surgery to support tissue regeneration and promote periodontal health in patients with gum disease. Periodontists employ DBM grafts in guided tissue regeneration (GTR) procedures to facilitate the regeneration of periodontal ligament and alveolar bone.
The adoption of DBM in the medical field has grown significantly over the years. One of the primary drivers of DBM adoption is its demonstrated clinical efficacy in promoting bone regeneration and facilitating the healing process. Clinical studies and real-world evidence have shown that DBM effectively stimulates osteogenesis and supports bone growth, making it a valuable grafting material in orthopaedic and dental surgeries.
The growing healthcare sector in Dubai entails the development of new hospitals, medical centres, and specialty clinics equipped with state-of-the-art medical technologies and facilities. According to official statistics released by the Dubai Health Authority (DHA) for 2022, with a remarkable 45% rise in just five years, the emirate now has 4,482 private medical institutions. A variety of medical disciplines and subspecialties are treated at these facilities. Thus, the rising aging population and expansion of the healthcare sector are propelling the market’s growth.
Based on End-use, the market is segmented into Outpatient Facilities, and Hospitals. Based on Product Type, the market is segmented into Putty, Fiber, Sponge, Paste, Gel, and Others. Based on Application, the market is segmented into Spinal Fusion, Dental, Joint Reconstruction, Hand, Foot, & Ankle, Long Bone, and Craniomaxillofacial. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The Brazil market dominated the LAMEA Demineralized Bone Matrix Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $39 million by 2030. The Argentina market is showcasing a CAGR of 8.7% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7.8% during (2023 - 2030).
DBM-based grafting materials facilitate the successful placement of dental implants and improve long-term implant outcomes in patients requiring tooth replacement. In addition, DBM is utilized in periodontal surgery to support tissue regeneration and promote periodontal health in patients with gum disease. Periodontists employ DBM grafts in guided tissue regeneration (GTR) procedures to facilitate the regeneration of periodontal ligament and alveolar bone.
The adoption of DBM in the medical field has grown significantly over the years. One of the primary drivers of DBM adoption is its demonstrated clinical efficacy in promoting bone regeneration and facilitating the healing process. Clinical studies and real-world evidence have shown that DBM effectively stimulates osteogenesis and supports bone growth, making it a valuable grafting material in orthopaedic and dental surgeries.
The growing healthcare sector in Dubai entails the development of new hospitals, medical centres, and specialty clinics equipped with state-of-the-art medical technologies and facilities. According to official statistics released by the Dubai Health Authority (DHA) for 2022, with a remarkable 45% rise in just five years, the emirate now has 4,482 private medical institutions. A variety of medical disciplines and subspecialties are treated at these facilities. Thus, the rising aging population and expansion of the healthcare sector are propelling the market’s growth.
Based on End-use, the market is segmented into Outpatient Facilities, and Hospitals. Based on Product Type, the market is segmented into Putty, Fiber, Sponge, Paste, Gel, and Others. Based on Application, the market is segmented into Spinal Fusion, Dental, Joint Reconstruction, Hand, Foot, & Ankle, Long Bone, and Craniomaxillofacial. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Zimmer Biomet Holdings, Inc.
- Medtronic PLC
- Johnson & Johnson
- Stryker Corporation
- Arthrex, Inc.
- Globus Medical, Inc.
- Berkeley Advanced Biomaterials
- Xtant Medical Holdings, Inc.
- Orthofix Medical Inc.
- Institut Straumann AG
Market Report Segmentation
By End-use- Outpatient Facilities
- Hospitals
- Putty
- Fiber
- Sponge
- Paste
- Gel
- Others
- Government
- Energy
- Defense
- Agriculture & Forestry
- Media & Entertainment
- Civil Engineering & Archaeology
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Demineralized Bone Matrix Market by End-use
Chapter 5. LAMEA Demineralized Bone Matrix Market by Product Type
Chapter 6. LAMEA Demineralized Bone Matrix Market by Application
Chapter 7. LAMEA Demineralized Bone Matrix Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Zimmer Biomet Holdings, Inc.
- Medtronic PLC
- Johnson & Johnson
- Stryker Corporation
- Arthrex, Inc.
- Globus Medical, Inc.
- Berkeley Advanced Biomaterials
- Xtant Medical Holdings, Inc.
- Orthofix Medical Inc.
- Institut Straumann AG
Methodology
LOADING...
